EP1904081A4 - COMPOSITIONS AND METHODS FOR CONTROLLING AN ANGIOGENESIS WITH CUPREDOXINES - Google Patents
COMPOSITIONS AND METHODS FOR CONTROLLING AN ANGIOGENESIS WITH CUPREDOXINESInfo
- Publication number
- EP1904081A4 EP1904081A4 EP06787787A EP06787787A EP1904081A4 EP 1904081 A4 EP1904081 A4 EP 1904081A4 EP 06787787 A EP06787787 A EP 06787787A EP 06787787 A EP06787787 A EP 06787787A EP 1904081 A4 EP1904081 A4 EP 1904081A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- cupredoxins
- compositions
- methods
- controlling angiogenesis
- angiogenesis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/415—Assays involving biological materials from specific organisms or of a specific nature from plants
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/32—Cardiovascular disorders
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Rheumatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Ophthalmology & Optometry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Pain & Pain Management (AREA)
- Dermatology (AREA)
- Biochemistry (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Cardiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US70029705P | 2005-07-19 | 2005-07-19 | |
| US11/244,105 US7691383B2 (en) | 2004-10-07 | 2005-10-06 | Cupredoxin derived transport agents and methods of use thereof |
| US76474906P | 2006-02-03 | 2006-02-03 | |
| US11/436,592 US7381701B2 (en) | 2001-02-15 | 2006-05-19 | Compositions and methods for treating conditions related to ephrin signaling with cupredoxins |
| PCT/US2006/027940 WO2007024368A2 (en) | 2005-07-19 | 2006-07-19 | Compositions and methods to control angiogenesis with cupredoxins |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EP1904081A2 EP1904081A2 (en) | 2008-04-02 |
| EP1904081A4 true EP1904081A4 (en) | 2008-12-03 |
Family
ID=37772089
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP06787787A Withdrawn EP1904081A4 (en) | 2005-07-19 | 2006-07-19 | COMPOSITIONS AND METHODS FOR CONTROLLING AN ANGIOGENESIS WITH CUPREDOXINES |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP1904081A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2009502797A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20080034905A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2006284490A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BRPI0615555A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2615560A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL188691A0 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2008000993A (cg-RX-API-DMAC7.html) |
| NO (1) | NO20080829L (cg-RX-API-DMAC7.html) |
| WO (1) | WO2007024368A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8158574B2 (en) * | 2004-10-07 | 2012-04-17 | Cdg Therapeutics, Inc. | Compositions and methods to prevent cancer with cupredoxins |
| EP2061498A4 (en) * | 2006-09-14 | 2009-11-04 | Univ Illinois | COMPOSITIONS AND METHOD FOR CANCER PREPARATION WITH CUPREDOXINES |
| AU2007329375A1 (en) | 2006-12-04 | 2008-06-12 | The Board Of Trustees Of The University Of Illinois | Compositions and methods to treat cancer with cupredoxins and CpG rich DNA |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005018662A1 (en) * | 2003-08-15 | 2005-03-03 | Board Of Trustees Of The University Of Illinois | Use of polypeptides of the cupredoxin family in cancer therapy |
| WO2006088508A2 (en) * | 2004-10-07 | 2006-08-24 | Ananda Chakrabarty | Cupredoxin derived transport agents and methods of use thereof |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2006277009A1 (en) * | 2005-05-20 | 2007-02-15 | The Board Of Trustees Of The University Of Illinois | Compositions and methods for treating conditions related to ephrin signaling with cupredoxins |
| JP2008545398A (ja) * | 2005-05-20 | 2008-12-18 | ザ・ボード・オブ・トラスティーズ・オブ・ザ・ユニバーシティ・オブ・イリノイ | キュプレドキシンおよびシトクロムcを用いてhiv感染を治療するための組成物および方法 |
| AU2006251742A1 (en) * | 2005-05-20 | 2006-11-30 | The Board Of Trustees Of The University Of Illinois | Compositions and methods for treating malaria with cupredoxin and cytochrome |
-
2006
- 2006-07-19 WO PCT/US2006/027940 patent/WO2007024368A2/en not_active Ceased
- 2006-07-19 AU AU2006284490A patent/AU2006284490A1/en not_active Abandoned
- 2006-07-19 BR BRPI0615555-3A patent/BRPI0615555A2/pt not_active IP Right Cessation
- 2006-07-19 MX MX2008000993A patent/MX2008000993A/es active IP Right Grant
- 2006-07-19 CA CA002615560A patent/CA2615560A1/en not_active Abandoned
- 2006-07-19 EP EP06787787A patent/EP1904081A4/en not_active Withdrawn
- 2006-07-19 JP JP2008522911A patent/JP2009502797A/ja active Pending
- 2006-07-19 KR KR1020087002477A patent/KR20080034905A/ko not_active Ceased
-
2008
- 2008-01-09 IL IL188691A patent/IL188691A0/en unknown
- 2008-02-15 NO NO20080829A patent/NO20080829L/no not_active Application Discontinuation
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005018662A1 (en) * | 2003-08-15 | 2005-03-03 | Board Of Trustees Of The University Of Illinois | Use of polypeptides of the cupredoxin family in cancer therapy |
| WO2006088508A2 (en) * | 2004-10-07 | 2006-08-24 | Ananda Chakrabarty | Cupredoxin derived transport agents and methods of use thereof |
Non-Patent Citations (3)
| Title |
|---|
| DATABASE GENESEQ [online] DERWENT PUBLICATIONS LTD., LONDON, GB; 23 June 2004 (2004-06-23), XU R. ET AL: "Azurin as bacterial protein with wide spectrum antitumor function and its use and medical composition", XP002499408, retrieved from EBI Database accession no. ADV69505 * |
| DATABASE UNIPROT [online] 21 July 1986 (1986-07-21), "RecName: Full=Azurin; Flags: Precursor;", retrieved from EBI accession no. UNIPROT:P00282 Database accession no. P00282 * |
| YAMADA TOHRU; FIALHO ARSENIO M; PUNJ VASU; BRATESCU LAURA; DAS GUPTA TAPAS K; CHAKRABARTY ANANDA M: "Internalization of bacterial redox protein azurin in mammalian cells: entry domain and specificity", CELLULAR MICROBIOLOGY, vol. 7, no. 10, 5 July 2005 (2005-07-05) - 25 October 2005 (2005-10-25), pages 1418 - 1431, XP002499203 * |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2007024368A3 (en) | 2007-10-11 |
| WO2007024368A2 (en) | 2007-03-01 |
| IL188691A0 (en) | 2008-08-07 |
| AU2006284490A8 (en) | 2008-02-28 |
| KR20080034905A (ko) | 2008-04-22 |
| NO20080829L (no) | 2008-04-02 |
| EP1904081A2 (en) | 2008-04-02 |
| CA2615560A1 (en) | 2007-03-01 |
| AU2006284490A1 (en) | 2007-03-01 |
| BRPI0615555A2 (pt) | 2009-07-14 |
| MX2008000993A (es) | 2008-03-19 |
| JP2009502797A (ja) | 2009-01-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0613033A2 (pt) | composição oral | |
| EP1732906A4 (en) | 2-AMINOTHIAZONE COMPOUNDS SUITABLE AS ASPARTYL PROTEASE INHIBITORS | |
| PL1896063T3 (pl) | Kompozycja immunogenna | |
| DE602004009780D1 (de) | Neue strahlenhärtbare Zusammensetzungen | |
| ITMI20041252A1 (it) | Composizioni perfluoroelastomeriche | |
| EP1788047A4 (en) | WATER REPELLENT / OIL-REPELLING COMPOSITION | |
| EP1844189A4 (en) | PROBENAHMEMOPP | |
| DE602006012777D1 (de) | Horizontale Niederspannvorrichtung | |
| EP1839669A4 (en) | NEW ANGIOGENESEHEMMER | |
| DE602005005064D1 (de) | Neue 4-benzylidenpiperidinderivate | |
| DE602004008217D1 (de) | Einfach dispergierbare konzentrierte Esterquat Zusammensetzungen | |
| GB0414594D0 (en) | Aqueous composition 1 | |
| DE602004008602D1 (de) | Neue strahlenhärtbare Zusammensetzungen | |
| DE602005017191D1 (de) | Geruchsreduzierte waschstück-zusammensetzung | |
| EP1854467A4 (en) | COMPOSITION FOR IMMUNACTIVATION | |
| ATE425167T1 (de) | Neue pyridothienopyrimidinderivate | |
| ZA200804391B (en) | Novel vinylogous acids derivatives | |
| DE602006020013D1 (de) | EGPWS-Klappenpositionsverbesserung | |
| FR2871686B1 (fr) | Composition anti-decoloration | |
| ITMI20041447A1 (it) | Composizione farmaceutica comprendente gabapentina | |
| ATE445604T1 (de) | Neue 2,6-diaminopyridin-3-on-derivate | |
| NO20050614L (no) | Refractory compositions | |
| ITBO20050074U1 (it) | Manufatto per l'edilizia | |
| FR2880793B1 (fr) | Prothese d'epaule | |
| NO20042027D0 (no) | Oral composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| 17P | Request for examination filed |
Effective date: 20080117 |
|
| AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR |
|
| AX | Request for extension of the european patent |
Extension state: AL BA HR MK YU |
|
| RAX | Requested extension states of the european patent have changed |
Extension state: RS Extension state: MK Extension state: HR Extension state: BA Extension state: AL |
|
| A4 | Supplementary search report drawn up and despatched |
Effective date: 20081105 |
|
| 17Q | First examination report despatched |
Effective date: 20090219 |
|
| DAX | Request for extension of the european patent (deleted) | ||
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
| 18D | Application deemed to be withdrawn |
Effective date: 20121009 |